The board of directors of National Investments Fund Limited announced that the company and Medisun Holdings Limited, together with Medisun Group, has engaged Mr. Brock Reeve as Chief Investment Consultant of Stem Cell & Regenerative Medicine. Mr. Brock Reeve is presently an executive director of the Harvard Stem Cell Institute, and was graduated from Yale University and Harvard Business School. Mr. Brock Reeve was responsible for the operation and strategy of the Harvard Stem Cell Institute.

As the Chief Investment Consultant of Stem Cell & Regenerative Medicine of the Company and its associated company, Medisun Holdings, Mr. Brock Reeve will organize and lead a professional investment team to attend closely on the latest technologies in stem cell and regenerative medicine in Europe, the United States of America, Japan and other overseas market and evaluate their investment value, to pay attention to and invest in the leading stem cell and regenerative medicine technologies in the world, and to participate actively in the conduct of the clinical trials and product commercialization in Asia for the stem cell investments by the Company and the Medisun Group.